Gastric Cancer
Copyright ©The Author(s) 2002.
World J Gastroenterol. Apr 15, 2002; 8(2): 224-229
Published online Apr 15, 2002. doi: 10.3748/wjg.v8.i2.224
Table 1 Inhibitory effect of c9,t11-CLA on DNA synthesis in SGC-7901 cells (n = 6)
c9,t11-CLA (μmol/L)3H-TdR incorporation (cpm, ¯x ± s)
Inhibitory Rate (%)
24 h48 h24 h48 h
02165 ± 1723598 ± 603
251810 ± 5053093 ± 32316.414.0
502208 ± 2912640 ± 607a-2.026.6
1002065 ± 2612063 ± 495b4.642.7
200472 ± 260b88 ± 15b78.297.5
Table 2 Positive rates of cyclin A, B1, and D1 on SGC-7901 cells treated with c9,t11-CLA (%)
c9,t11-CLA (μmol/L)24 h
48 h
Cylin ACylin B1Cyclin D1Cylin ACylin B1Cyclin D1
010.74.29.55.95.16.0
2511.04.83.6b8.55.53.7b
507.92.53.5b5.03.1b3.7b
1004.4b2.6b2.1b1.3b0.7b0.6b
2002.3b1.8b0.4b0.5b0.6b0
Table 3 Positive rates of p16ink4a and p21waf1 on SGC-7901 cells treated with c9,t11-CLA (%)
c9,t11-CLA (μmol/L)24 h
48 h
p16ink4ap21waf1p16ink4ap21waf1
01.00.20.80.6
250.71.4b0.20.8
501.41.0b3.0b2.5b
1002.8b4.1b4.6b3.8b
2003.6b5.2b5.0b6.3b